BB Biotech AG (BION.S)
BION.S on Swiss Exchange
66.85CHF
23 May 2018
66.85CHF
23 May 2018
Change (% chg)
CHF-0.20 (-0.30%)
CHF-0.20 (-0.30%)
Prev Close
CHF67.05
CHF67.05
Open
CHF67.00
CHF67.00
Day's High
CHF67.00
CHF67.00
Day's Low
CHF66.25
CHF66.25
Volume
71,814
71,814
Avg. Vol
109,896
109,896
52-wk High
CHF74.00
CHF74.00
52-wk Low
CHF54.20
CHF54.20
About
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)
Overall
| Beta: | 1.16 |
| Market Cap(Mil.): | CHF3,731.19 |
| Shares Outstanding(Mil.): | 55.40 |
| Dividend: | 2.75 |
| Yield (%): | 4.08 |
Financials
| BION.S | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 4.38 | 84.06 | 32.75 |
| EPS (TTM): | 15.37 | -- | -- |
| ROI: | 28.44 | 1.57 | 14.38 |
| ROE: | 28.44 | 2.43 | 16.07 |
BRIEF-BB Biotech Q1 Profit Of CHF 28 Mln
* DGAP-ADHOC: BB BIOTECH SHARE GAINS VALUE IN FIRST QUARTER 2018 - SEVERAL LARGE-CAP BIOTECH COMPANIES TRADING AT WELL BELOW FUNDAMENTAL VALUE
BRIEF-BB Biotech FY Net Result Turns to Profit Of CHF 688 Million
* FY NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN IN PREVIOUS PERIOD
BRIEF-BB Biotech to propose 3.30 Sfr dividend for 2017
* SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER
BRIEF-BB Biotech Reports 5.6% Passive Stake In Voyager Therapeutics
* BB BIOTECH AG REPORTS 5.6% PASSIVE STAKE IN VOYAGER THERAPEUTICS AS OF JAN 3 - SEC FILING Source text: (http://bit.ly/2CZEeZD) Further company coverage:
Estimates